Identifying pain characteristics to improve pain medication effectiveness
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development
This study is looking at how each person's experience of pain can help doctors find the best pain relief options for them, so if you have neuropathic pain, you might get treatments that work better just for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10724809 on NIH RePORTER |
What this research studies
This research focuses on understanding how individual differences in pain perception can help tailor pain treatments for better outcomes. By using a technique called quantitative sensory testing, researchers aim to identify specific sensory profiles that can predict how well patients will respond to different pain medications. The goal is to develop a more personalized approach to pain management, moving away from a one-size-fits-all strategy. This could lead to more effective treatments for those suffering from neuropathic pain.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from neuropathic pain who have not found relief with standard pain medications.
Not a fit: Patients with acute pain conditions or those who do not have neuropathic pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the effectiveness of pain medications for patients with neuropathic pain.
How similar studies have performed: Preliminary evidence suggests that identifying pain phenotypes can predict treatment outcomes, indicating potential success for this approach.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Freeman, Roy — Beth Israel Deaconess Medical Center
- Study coordinator: Freeman, Roy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.